YH14755

· Yuhan Corporation

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for YH14755, covering 2014-10-09 to 2018-10-03. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes [Phase 3]